The CGCI program supports cutting-edge genomics research of adult and pediatric cancers. CGCI investigators develop and apply advanced sequencing methods that examine genomes, exomes, and transcriptomes within various types of tumors.
The National Cancer Institute (NCI) Genomic Data Commons (GDC) provides access to data from the Cancer Genome Characterization Initiative (CGCI) program. CGCI data is stored in the GDC and harmonized against a common reference genome. CGCI metadata is categorized and mapped to the GDC Data Model.
Program Summary
The CGCI program supports cutting-edge genomics research on adult and pediatric cancers. CGCI investigators develop and apply advanced sequencing methods that examine genomes, exomes, and transcriptomes of tumors. From the resulting molecular data, they can identify novel genetic abnormalities, which may contribute to cancer pathogenesis. Revealing the underlying causes of cancer will lead to better cancer detection, diagnosis, and treatment for patients in the US and different parts of the world.
Supported Cancer Studies
CGCI fosters research projects that focus on a variety of cancer types. CGCI data in the GDC is available for the following disease types:
- Burkitt's Lymphoma (BLGSP)
- HIV+ Associated Cancers - HIV+ Diffuse Large B-Cell Lymphoma (HTMCP- DLBCL), HIV+ Cervical Cancers (HTMCP-CC), HIV+ Lung Cancers (HTMCP-LC)
- Medulloblastoma (MB)
- Non-Hodgkin's Lymphoma (NHL) - Diffuse Large B-Cell Lymphoma (NHL-DLBCL), Follicular Lymphoma (NHL-FL)